Steroid profile in urine: a useful tool in the diagnosis and follow-up of adrenocortical carcinoma
1990 (English)In: Acta Endocrinologica, ISSN 0001-5598, Vol. 122, no 5, 656-663 p.Article in journal (Refereed) Published
The urinary steroid profile was determined in 24 patients with adrenocortical carcinoma. Seventeen of the patients had Cushing's syndrome, virilization or feminization, and 7 had no signs of endocrine disease. Seven of the 11 patients still alive are free of disease, after a follow-up period of 5-75 months. The steroid profile varied widely between the patients with adrenocortical carcinoma. Patients with Cushing's syndrome had increased levels of cortisol metabolites and those with virilism had raised excretion of androgen metabolites. Six of the patients with adrenocortical carcinoma showed normal values of these metabolites. In 23 of the 24 patients the excretion of 3 beta-hydroxy-5-ene steroids and/or metabolites of cortisol precursors, such as tetrahydro-11-deoxycortisol, were significantly increased, compared with healthy controls or patients with adrenal adenomas. These findings suggest a relative deficit or low activity of 3 beta-hydroxysteroid dehydrogenase/delta isomerase and/or 11 beta-hydroxylase in tumour tissue. In the single patient where the steroid profile failed to indicate malignancy, hypercortisolism was seen and the tumour mass was small. The steroid excretion normalized after radical surgery and decreased in patients responding to chemotherapy. During recurred disease the metabolites of 3 beta-hydroxy-5-ene steroids and/or cortisol precursors increased, but in some patients the excretory pattern then was different from that seen before treatment
Place, publisher, year, edition, pages
1990. Vol. 122, no 5, 656-663 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-150949DOI: 10.1530/acta.0.1220656OAI: oai:DiVA.org:uu-150949DiVA: diva2:409446